GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (BUD:BAYER) » Definitions » Cyclically Adjusted Price-to-FCF

Bayer AG (BUD:BAYER) Cyclically Adjusted Price-to-FCF : 5.23 (As of May. 23, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Bayer AG Cyclically Adjusted Price-to-FCF?

As of today (2024-05-23), Bayer AG's current share price is Ft10998.00. Bayer AG's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was Ft2,103.83. Bayer AG's Cyclically Adjusted Price-to-FCF for today is 5.23.

The historical rank and industry rank for Bayer AG's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

BUD:BAYER' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 4.78   Med: 13.84   Max: 33.49
Current: 5.4

During the past years, Bayer AG's highest Cyclically Adjusted Price-to-FCF was 33.49. The lowest was 4.78. And the median was 13.84.

BUD:BAYER's Cyclically Adjusted Price-to-FCF is ranked better than
95.77% of 307 companies
in the Drug Manufacturers industry
Industry Median: 33.22 vs BUD:BAYER: 5.40

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Bayer AG's adjusted free cash flow per share data for the three months ended in Mar. 2024 was Ft-1,025.738. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is Ft2,103.83 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bayer AG Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Bayer AG's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Cyclically Adjusted Price-to-FCF Chart

Bayer AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.47 9.52 9.29 8.77 6.12

Bayer AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.19 9.92 8.81 6.12 5.35

Competitive Comparison of Bayer AG's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - General subindustry, Bayer AG's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bayer AG's Cyclically Adjusted Price-to-FCF falls into.



Bayer AG Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Bayer AG's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=10998.00/2103.83
=5.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bayer AG's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1025.738/125.0381*125.0381
=-1,025.738

Current CPI (Mar. 2024) = 125.0381.

Bayer AG Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 627.680 99.543 788.445
201409 707.585 99.823 886.324
201412 688.559 99.543 864.917
201503 177.887 99.717 223.059
201506 654.657 100.417 815.174
201509 813.156 100.417 1,012.536
201512 451.701 99.717 566.404
201603 461.191 100.017 576.568
201606 675.927 100.717 839.151
201609 1,161.793 101.017 1,438.062
201612 781.665 101.217 965.628
201703 186.725 101.417 230.215
201706 832.724 102.117 1,019.637
201709 1,035.354 102.717 1,260.342
201712 644.768 102.617 785.645
201803 153.654 102.917 186.680
201806 811.444 104.017 975.428
201809 591.809 104.718 706.650
201812 763.173 104.217 915.641
201903 281.603 104.217 337.862
201906 469.405 105.718 555.191
201909 621.728 106.018 733.271
201912 879.710 105.818 1,039.499
202003 -249.036 105.718 -294.549
202006 748.721 106.618 878.077
202009 607.139 105.818 717.419
202012 -62.797 105.518 -74.414
202103 -1,338.938 107.518 -1,557.120
202106 658.702 108.486 759.204
202109 924.605 109.435 1,056.437
202112 782.887 110.384 886.824
202203 -430.370 113.968 -472.173
202206 597.144 115.760 645.003
202209 693.913 118.818 730.240
202212 668.879 119.345 700.787
202303 -1,563.027 122.402 -1,596.684
202306 -48.048 123.140 -48.788
202309 734.396 124.195 739.384
202312 1,827.870 123.773 1,846.554
202403 -1,025.738 125.038 -1,025.738

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bayer AG  (BUD:BAYER) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Bayer AG Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Bayer AG's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG (BUD:BAYER) Business Description

Industry
Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Bayer AG (BUD:BAYER) Headlines

No Headlines